Home Stocks Abbott India Ltd

Abbott India Ltd

The live share price of Abbott India Ltd (ABBOTINDIA) as on 08 Dec 10:23am is ₹22,858 from NSE/BSE.

ABBOTINDIA NSE

₹22,858 ▼-0.93% (-215.4)

As on Dec 08, 2023 03:53 PM IST

How do you feel today about Abbott India Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

45.34

PB Ratio

15.38

Dividend Yield

1.41%

Sector PB

5.11

Sector PE

44.48

Sector Div Yld

0.7%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹49,029 Cr

Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

The following charts display the financial performance of the Abbott India Ltd (ABBOTINDIA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Abbott India Ltd (ABBOTINDIA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹49,029 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	5,533 Cr	+10.32%
Operating Expense	216 Cr	+83.53%
Net Income	949 Cr	+18.87%
Net Profit Margin	17.16%	+7.79%
Earning Per Share	446	+18.87%
EBITDA	1,359 Cr	+16.73%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	1,937 Cr	-29.54%
Total Assets	4,555 Cr	+7.85%
Total Liabilities	1,366 Cr	-2.66%
Total Equity	3,188 Cr	+13.08%
Shares Outstanding	2.12 Cr	-0.23%
Price to Book	14.7	+11.39%
Return on Assets	21.63%	+9.19%
Return on Capital	40.45 Cr	+3.8%

Cash Flows

(INR)		Y/Y Change
Net Income	949 Cr	+18.87%
Cash from Operations	893 Cr	-5.73%
Cash from Investing	-147 Cr	-62.68%
Cash from Financing	-638 Cr	+0.21%
Net Change in Cash	106 Cr	-225.01%
Free Cash Flow	859 Cr	-4.9%

Shareholding Pattern

Total Promoter Holding

74.99%

Unpledged

Foreign Institutions

0.18%

Foreign Institutions

Retail & Others

16%

Retail & Others

Other Parties

Other Domestic Institutions

1.51%

Insurance Firms

Others

Mutual Funds

7.32%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

34.78

1Y Return

▲26%

CIPLA

Cipla Ltd

PE Ratio

28.59

1Y Return

▲10.08%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

18.92

1Y Return

▲32.31%

MANKIND

Mankind Pharma Ltd

PE Ratio

51.24

1Y Return

▲37.3%

Latest News

Trade setup for Wednesday: 15 things to know before opening bell

3 days ago on Moneycontrol

Change since news ▲2.31%

A short build-up was seen in 55 stocks, which were Abbott India, M&M Financial Services, ICICI Prudential Life Insurance Company, L&T Technology Services, and IRCTC.

Pharma Q2 Results Review - Splendid Quarter, Positive Momentum To Accelerate Ahead: ICICI Securities

2 weeks ago on Bloomberg Quint

Change since news ▲4.31%

Cipla, Aurobindo Pharma, Ajanta Pharma and Abbott India are our top picks in the space.

Abbott India trades lower after Q2 results, CLSA downgrades stock to outperform

4 weeks ago on Moneycontrol

Change since news ▲3.58%

Analysts at CLSA have downgraded the stock to outperform from Buy and have raised the target price to Rs 27,500 per share.

FAQs on Abbott India Ltd

How to buy Abbott India Ltd stocks?

You can easily buy the stocks/shares of Abbott India Ltd (ABBOTINDIA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Abbott India Ltd?

The stock price of Abbott India Ltd as on 08 Dec 2023 is ₹22,858

What is the 52-week High and Low of Abbott India Ltd?

The 52-week high and low of Abbott India Ltd (ABBOTINDIA) is ₹24,744.25 and ₹19,900.

What is the PE and PB ratio of Abbott India Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Abbott India Ltd are 45.34 and 15.38 respectively.

What are the peers or stocks similar to Abbott India Ltd?

The peers or stocks similar to Abbott India Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Abbott India Ltd belong to?

Abbott India Ltd (ABBOTINDIA) belongs to the Pharmaceuticals sector.

What is the Market Cap of Abbott India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Abbott India Ltd (ABBOTINDIA) is ₹49,029 Cr as of 08 Dec 2023

Can't decide whether or not to buy Abbott India Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.